EdgarLookup

Estrella Immunopharma, Inc. — 8-K Filings

58 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Estrella Immunopharma, Inc. (ESLAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Estrella Immunopharma, Inc. has filed 58 8-K documents with the SEC since 2021. To view all SEC filings by Estrella Immunopharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 25-NSE 3 4 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A CERT CORRESP DEF 14A DEFA14A EFFECT NT 10-Q PRE 14A PRER14A S-1 S-1/A S-3 S-4 S-4/A S-8 SC 13D SC 13G SC 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURREN REPORT 0001213900-26-003998 Jan 13, 2026 Jan 7, 2026
8-K CURRENT REPORT 0001213900-26-001777 Jan 6, 2026 Jan 5, 2026
8-K CURRENT REPORT 0001213900-25-118097 Dec 4, 2025 —
8-K CURRENT REPORT 0001213900-25-107249 Nov 6, 2025 Nov 3, 2025
8-K CURRENT REPORT 0001213900-25-093197 Sep 29, 2025 Sep 23, 2025
8-K CURRENT REPORT 0001213900-25-092471 Sep 26, 2025 Sep 22, 2025
8-K CURRENT REPORT 0001213900-25-072746 Aug 7, 2025 Aug 1, 2025
8-K CURRENT REPORT 0001213900-25-051361 Jun 5, 2025 —
8-K CURRENT REPORT 0001213900-25-050329 Jun 3, 2025 May 30, 2025
8-K CURRENT REPORT 0001213900-25-048597 May 29, 2025 —
8-K FORM 8-K 0001213900-25-039261 May 2, 2025 Apr 30, 2025
8-K CURRRENT REPORT 0001213900-25-015851 Feb 21, 2025 —
8-K FORM 8-K 0001213900-25-015364 Feb 20, 2025 Feb 19, 2025
8-K CURRENT REPORT 0001213900-24-109285 Dec 16, 2024 —
8-K CURRENT REPORT 0001213900-24-106238 Dec 6, 2024 Dec 4, 2024
8-K CURRENT REPORT 0001213900-24-102899 Nov 26, 2024 Nov 25, 2024
8-K CURRENT REPORT 0001213900-24-102134 Nov 25, 2024 —
8-K CURRENT REPORT 0001213900-24-095506 Nov 7, 2024 Nov 1, 2024
8-K CURRENT REPORT 0001213900-24-071174 Aug 20, 2024 Aug 14, 2024
8-K CURRENT REPORT 0001213900-24-065292 Aug 6, 2024 Jul 31, 2024
8-K CURRENT REPORT 0001213900-24-058085 Jul 2, 2024 Jun 26, 2024
8-K CURRENT REPORT 0001213900-24-042444 May 13, 2024 —
8-K CURRENT REPORT 0001213900-24-031716 Apr 10, 2024 —
8-K CURRENT REPORT 0001213900-24-021186 Mar 11, 2024 Mar 8, 2024
8-K CURRENT REPORT 0001213900-24-020566 Mar 7, 2024 Mar 4, 2024
8-K CURRENT REPORT 0001213900-24-009325 Feb 2, 2024 Jan 30, 2024
8-K CURRENT REPORT 0001213900-24-007723 Jan 30, 2024 —
8-K FORM 8-K 0001013762-23-002216 Oct 5, 2023 Sep 29, 2023
8-K CURRENT REPORT 0001213900-23-077995 Sep 20, 2023 Sep 14, 2023
8-K CURRENT REPORT 0001213900-23-077392 Sep 18, 2023 —
8-K CURRENT REPORT 0001213900-23-069046 Aug 18, 2023 —
8-K CURRENT REPORT 0001213900-23-061514 Aug 1, 2023 Jul 31, 2023
8-K CURRENT REPORT 0001213900-23-059815 Jul 26, 2023 Jul 25, 2023
8-K CURRENT REPORT 0001213900-23-058655 Jul 21, 2023 Jul 20, 2023
8-K CURRENT REPORT 0001213900-23-058025 Jul 19, 2023 Jul 18, 2023
8-K CURRENT REPORT 0001213900-23-058024 Jul 19, 2023 Jul 17, 2023
8-K CURRENT REPORT 0001213900-23-056454 Jul 12, 2023 Jul 11, 2023
8-K FORM 8-K 0001575872-23-001032 Jun 23, 2023 Jun 22, 2023
8-K FORM 8-K 0001575872-23-001000 Jun 20, 2023 Jun 16, 2023
8-K FORM 8-K 0001575872-23-000920 Jun 9, 2023 Jun 6, 2023
8-K FORM 8-K 0001575872-23-000800 May 19, 2023 —
8-K FORM 8-K 0001575872-23-000629 Apr 26, 2023 —
8-K FORM 8-K 0001575872-23-000606 Apr 24, 2023 Apr 20, 2023
8-K FORM 8-K 0001575872-23-000592 Apr 21, 2023 Apr 19, 2023
8-K FORM 8-K 0001575872-23-000556 Apr 13, 2023 Apr 12, 2023
8-K FORM 8-K 0001575872-23-000519 Apr 5, 2023 Apr 3, 2023
8-K FORM 8-K 0001575872-23-000384 Mar 20, 2023 Mar 17, 2023
8-K FORM 8-K 0001575872-23-000316 Mar 3, 2023 —
8-K FORM 8-K 0001575872-23-000296 Feb 21, 2023 Feb 17, 2023
8-K FORM 8-K 0001575872-23-000129 Jan 24, 2023 Jan 19, 2023